20/20 Onsite Receives Safety Excellence Award, Reinforcing Commitment to Unmatched Clinical Trial Support

Associated Press

13-03-2025

20/20 Onsite, a leader in delivering point-of-need ophthalmic assessments for clinical trials, is proud to announce its recognition with the Safety Excellence Award by Whip Around. This accolade underscores the company's unwavering commitment to operational excellence and safety in delivering point-of-need eye care services.
Based on rigorous evaluation criteria, the award highlights 20/20 Onsite's exceptional performance in fleet safety and inspection participation. Key achievements that contributed to this recognition include:
Nearly 50% of assets inspected (over 600 inspections submitted) with zero identified defects over the past year.
Exceptional inspection efficiency, with an average completion time of 3 minutes and 24 seconds.
'We're honored to receive this Safety Excellence Award, recognizing our commitment to safety in mobile optometry. With over 2,000,000 miles driven across 48 states, delivering state-of-the-art care, we know safety is the foundation of our success. It's where excellence begins and what makes our mission possible every day,' said Ivan Quiroz, VP, Clinic Operations at 20/20 Onsite.
'Safety is a fundamental pillar of our commitment to providing industry-leading point-of-need ophthalmic assessments for clinical trials and the broader community,' said Sonali Bloom, CEO of 20/20 Onsite. 'Receiving this award reaffirms our dedication to operational excellence, ensuring our services are convenient for patients and meet the highest safety standards.'
This recognition reflects 20/20 Onsite's relentless pursuit of quality. The company's rigorous inspection protocols and proactive driver engagement ensure that its mobile clinics are always prepared to deliver consistent, reliable service—an essential factor in supporting critical ophthalmic assessment timelines.
As the industry standard for point-of-need eye care assessments, 20/20 Onsite focuses on expanding its capabilities while maintaining a steadfast commitment to safety and quality.
For more information about 20/20 Onsite and its services, visit 2020onsite.com.
About 20/20 Onsite
20/20 Onsite is a healthcare services company providing clinical trial solutions that are transforming the delivery of vision care by radically improving access for patients through state-of-the-art Mobile Vision Clinics. Their integrated point-of-need service delivery platform has taken high-value eye assessment services directly to patients at work, at school, in neighborhoods, and at clinical research sites. During the pandemic, 20/20 Onsite began bringing ophthalmic assessments to patients in clinical trials or post-marketing safety surveillance programs across the country, increasing access to clinical research. They are enabling and accelerating fundamental trends toward the consumerization of care and the decentralization of clinical trials.
20/20 Onsite has served over 85,000 patients, including 34 clinical trials, met 100% of screening timelines across their operations, and consistently reports patient NPS scores of over 95.
SOURCE: 20/20 Onsite
Copyright Business Wire 2025.
PUB: 03/13/2025 10:44 AM/DISC: 03/13/2025 10:45 AM